Monix joins Future of Health Grant at Level 2
Monix joins the autumn 2025 cohort with equity-free support for continuous hormone monitoring.
Monix was selected for Level 2 of the Future of Health Grant in the cohort announced on September 9, 2025. The programme provides equity-free support, tailored coaching and connections across the healthcare sector. Monix’s individual allocation was not disclosed.
Based in Allschwil, Monix is developing wearable sensing for women’s hormone health. Its aim is to make hormone patterns visible continuously rather than relying on occasional measurements, with fertility and IVF among its intended applications.
The cohort announcement placed Monix in the programme’s second support level. The selection also gives the company access to an expanded European partner network as Future of Health Grant works with accelerators in France, Germany and Spain.